Veradermics showed promising results for its hair loss pill, aiming to be the first FDA-approved oral treatment in 30 years.

MANE · Veradermics Incorporated

The AI's read

Patient reports and clinician ratings also showed improvement, and the company reported no treatment-related serious events over 12 months. Those findings strengthen the case for the pill. It remains investigational, so approval and sales are not assured.